CDH2 and gastric cancer: Similar to the results of in vitro, we also found mJPYZ increased the protein expression levels of E-cadherin and decreased the levels of N-cadherin, Vimentin, which indicated that mJPYZ inhibited gastric cancer growth and EMT in the xenograft tumor (Figures 2D–G).